Motilal Oswal BSE Healthcare ETF
An open ended scheme replicating / tracking the BSE Healthcare Total Return Index
-
fundIcon:/content/dam/motilal-mf/fund-icons/MO_BSE_Healthcare_ETF.svg
-
typeOfScheme:An open ended scheme replicating / tracking the BSE Healthcare Total Return Index
-
dateAsOn:31 Oct 2026
-
schDetail:
-
exitLoad:
NIL
-
nfoStartDate: 13-Jul-2022
-
sebiCategory: ETF Fund
-
cmotsGroupCode: MO42978
-
dateOfAllotment: 2022-07-29
-
schemeName: Motilal Oswal BSE Healthcare ETF
-
nfoEndDate: 21-Jul-2022
-
fundCategoryCode: ETF
-
schcode: SH
-
-
minamount:
-
0:
- minredamt: NULL
- minsipamt: NULL
- minpuramt: NULL
- minaddpuramt: NULL
- optioncode: G
- plancode: GR
-
-
fundsTaggingSection:
- 0: motilal-oswal-amc:indian-equity-
- 1: motilal-oswal-amc:sector
- 2: motilal-oswal-amc:etf
-
planList:
-
0:
- sixth_char_name: R
- planNameOriginal: Regular Growth
- groupedCode: GRG
- groupedName: Regular-Growth
- optionCode: G
- optionName: Growth
- planCode: GR
- planName: Regular
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- dlPKey: DL_MF_SH_GR_GR
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
nav:
-
0:
- latnav: 50.9117
- optioncode: G
- plancode: GR
- prodcode: SHGR
- nav_date: 23-Jan-2026
- nav_amount: 41.79
- currNav: 53.72
- prevNAV: 53.74
- currNavDate: 11/12/2026 11:27:02
-
-
returns:
-
0:
- oneYear_Ret: 13.01
- oneYear_marketValue: 11300.777998512815
- threeYear_Ret: 22.86
- threeYear_marketValue: 18546.45931463085
- inception_Ret: 20.63
- inception_marketValue: 22230.63017431097
- latNavDate: 2026-10-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
-
xirr:
-
asOnDate: 2026-10-30
-
GD:
- SchemeCode: SH
- PlanType: Direct
- Return10Y_scheme: NA
- Return5Y_Addbenchmark: NA
- SinceInception_Addbenchmark: 8.3953
- Return1Y_scheme: 13.0458
- AsOnDate: 2026-10-30
- Return10Y_benchmark: NA
- Return3Y_scheme: 22.8628
- Return3Y_Addbenchmark: 7.7440
- Return10Y_Addbenchmark: NA
- Return5Y_scheme: NA
- NAV: 50.9117
- SinceInception_scheme: 20.6400
- SinceInception_benchmark: 20.9640
- Return7Y_scheme: NA
- Return1Y_benchmark: 13.2611
- Return1Y_Addbenchmark: -9.4745
- Return3Y_benchmark: 23.1847
- Return5Y_benchmark: NA
- Return7Y_Addbenchmark: NA
- Return7Y_benchmark: NA
- SchemeName: Motilal Oswal BSE Healthcare ETF
-
GP:
- SchemeCode: SH
- PlanType: Regular
- Return10Y_scheme: NA
- Return5Y_Addbenchmark: NA
- SinceInception_Addbenchmark: 8.3953
- Return1Y_scheme: 13.0458
- AsOnDate: 2026-10-30
- Return10Y_benchmark: NA
- Return3Y_scheme: 22.8628
- Return3Y_Addbenchmark: 7.7440
- Return10Y_Addbenchmark: NA
- Return5Y_scheme: NA
- NAV: 50.9117
- SinceInception_scheme: 20.6400
- SinceInception_benchmark: 20.9640
- Return7Y_scheme: NA
- Return1Y_benchmark: 13.2611
- Return1Y_Addbenchmark: -9.4745
- Return3Y_benchmark: 23.1847
- Return5Y_benchmark: NA
- Return7Y_Addbenchmark: NA
- Return7Y_benchmark: NA
- SchemeName: Motilal Oswal BSE Healthcare ETF
-
Call back
Share
Historical Performance
CAGR
planList:
-
0:
- sixth_char_name: R
- planNameOriginal: Regular Growth
- groupedCode: GRG
- groupedName: Regular-Growth
- optionCode: G
- optionName: Growth
- planCode: GR
- planName: Regular
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- dlPKey: DL_MF_SH_GR_GR
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
returns:
-
0:
- oneYear_Ret: 13.01
- oneYear_marketValue: 11300.777998512815
- threeYear_Ret: 22.86
- threeYear_marketValue: 18546.45931463085
- inception_Ret: 20.63
- inception_marketValue: 22230.63017431097
- latNavDate: 2026-10-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
Tracking Difference
Data as on 27 Feb 2026
- 1Y
- 3Y
- 5Y
- 10Y
- Inception
Scheme Inception Date -29-09-2023.
Performance is based on Compounded Annualised returns
Tracking Difference shall be disclosed only if the Scheme has completed 1 year
period
Tracking Difference is the difference in the performance between Scheme and its Benchmark
Periodic Returns
Data as on 31 Oct 2026
- 1Y
- 3Y
- 5Y
- 7Y
- 10Y
- Inception
-
schemeName: Motilal Oswal BSE Healthcare ETF
-
planList:
-
0:
- sixth_char_name: R
- planNameOriginal: Regular Growth
- groupedCode: GRG
- groupedName: Regular-Growth
- optionCode: G
- optionName: Growth
- planCode: GR
- planName: Regular
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- dlPKey: DL_MF_SH_GR_GR
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
returns:
-
0:
- oneYear_Ret: 13.01
- oneYear_marketValue: 11300.777998512815
- threeYear_Ret: 22.86
- threeYear_marketValue: 18546.45931463085
- inception_Ret: 20.63
- inception_marketValue: 22230.63017431097
- latNavDate: 2026-10-31
- prodcode: SHGR
- plancode: GR
- optioncode: G
- amfi_schcode: 150445
- cmt_schcode: 42978
- isin: INF247L01BB1
-
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-10-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 8.637157535347729
- inception_Ret: 10.705736641984554
- bmcode: 2046.0
- oneYear_marketValue: 10000.0
- threeYear_marketValue: 12821.395279847478
- inception_marketValue: 15423.283393834985
-
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them
Past Performance Calculator
Explore how much wealth you would have created by investing in our schemes using this SIP Calculator
Search a fund
Motilal Oswal Mid cap fund
SIP
Lumpsum
If you would have invested monthly
If you would have invested
10000
Tenure
10
Invested Amount
1200000
Current Value of Investment
Disclaimer:
- This calculator is provided for informational purposes only.
- The results are based on user inputs and should not be considered as investment advice. Users should seek the advice of a qualified financial professional before making any investment decisions.
- The creators of the calculator and its affiliates shall not be held responsible for any financial losses resulting from the use of the calculator.
- Past performance may or may not be sustained in the future and should not be used as a basis for comparison with other investments. Mutual Fund Investments are subject to market risks, read all scheme related documents carefully.
- SIP is allowed in select open ended schemes. Refer the Scheme SAI, SID, KIM for detailed information.
Why this fund?
Expertise
Backed by a decade of financial expertise, we focus on long-term wealth creation through early investment in promising midcaps.
High Conviction
A focused portfolio of ~35 high-conviction midcap stocks, carefully selected for their unique potential.
Quality and Growth
We prioritize business quality and management strength, guided by our QGLP investment philosophy.
*Based upon our current investment strategy.
Pioneering Growth
A House known for identifying high-growth themes that serve as compounding instruments & stand as formidable wealth creators.
Skin in the Game
Our promoters have invested a substantial ~71772 Cr.*, firmly aligning our interests with yours.
*Data as on 31st January 2024.
Disclaimer: The investment objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity.
Portfolio Composition
Download
-
Date As On: 31 Oct 2026
-
portfolioUrl: /content/dam/motilal-mf/sheets/fund-csvs/Month_End_Portfolio_October_2026/YO36.xlsx
-
holdings:
-
0:
- srNo: 1
- nameOfSecurity: Sun Pharmaceutical Industries Limited
- percentToNAV: 11.97%
-
1:
- srNo: 2
- nameOfSecurity: Divi's Laboratories Limited
- percentToNAV: 7.72%
-
2:
- srNo: 3
- nameOfSecurity: Laurus Labs Limited
- percentToNAV: 5.8%
-
3:
- srNo: 4
- nameOfSecurity: Apollo Hospitals Enterprise Limited
- percentToNAV: 5.35%
-
4:
- srNo: 5
- nameOfSecurity: Dr Reddys Laboratories Limited
- percentToNAV: 5.13%
-
5:
- srNo: 6
- nameOfSecurity: Cipla Limited
- percentToNAV: 4.87%
-
6:
- srNo: 7
- nameOfSecurity: Max Healthcare Institute Limited
- percentToNAV: 3.97%
-
7:
- srNo: 8
- nameOfSecurity: Torrent Pharmaceuticals Limited
- percentToNAV: 3.41%
-
8:
- srNo: 9
- nameOfSecurity: Lupin Limited
- percentToNAV: 3.04%
-
9:
- srNo: 10
- nameOfSecurity: Aurobindo Pharma Limited
- percentToNAV: 2.89%
-
10:
- srNo: 11
- nameOfSecurity: Fortis Healthcare Limited
- percentToNAV: 2.5%
-
11:
- srNo: 12
- nameOfSecurity: Glenmark Pharmaceuticals Limited
- percentToNAV: 2.15%
-
12:
- srNo: 13
- nameOfSecurity: Zydus Lifesciences Limited
- percentToNAV: 1.93%
-
13:
- srNo: 14
- nameOfSecurity: Alkem Laboratories Limited
- percentToNAV: 1.87%
-
14:
- srNo: 15
- nameOfSecurity: Mankind Pharma Limited
- percentToNAV: 1.73%
-
15:
- srNo: 16
- nameOfSecurity: IPCA Laboratories Limited
- percentToNAV: 1.68%
-
16:
- srNo: 17
- nameOfSecurity: Biocon Limited
- percentToNAV: 1.54%
-
17:
- srNo: 18
- nameOfSecurity: Gland Pharma Limited
- percentToNAV: 1.53%
-
18:
- srNo: 19
- nameOfSecurity: Sai Life Sciences Limited
- percentToNAV: 1.32%
-
19:
- srNo: 20
- nameOfSecurity: Acutaas Chemicals Limited
- percentToNAV: 1.29%
-
20:
- srNo: 21
- nameOfSecurity: Krishna Institute Of Medical Sciences Limited
- percentToNAV: 1.16%
-
21:
- srNo: 22
- nameOfSecurity: Aster DM Quality Care Limited
- percentToNAV: 1.15%
-
22:
- srNo: 23
- nameOfSecurity: Neuland Laboratories Limited
- percentToNAV: 1.06%
-
23:
- srNo: 24
- nameOfSecurity: Ajanta Pharma Limited
- percentToNAV: 0.99%
-
24:
- srNo: 25
- nameOfSecurity: Wockhardt Limited
- percentToNAV: 0.98%
-
25:
- srNo: 26
- nameOfSecurity: Piramal Pharma Limited
- percentToNAV: 0.93%
-
26:
- srNo: 27
- nameOfSecurity: Dr. Lal Path Labs Limited
- percentToNAV: 0.92%
-
27:
- srNo: 28
- nameOfSecurity: Abbott India Limited
- percentToNAV: 0.82%
-
28:
- srNo: 29
- nameOfSecurity: Onesource Specialty Pharma Limited
- percentToNAV: 0.76%
-
29:
- srNo: 30
- nameOfSecurity: Granules India Limited
- percentToNAV: 0.75%
-
30:
- srNo: 31
- nameOfSecurity: Narayana Hrudayalaya Limited
- percentToNAV: 0.75%
-
31:
- srNo: 32
- nameOfSecurity: Global Health Limited
- percentToNAV: 0.7%
-
32:
- srNo: 33
- nameOfSecurity: Shilpa Medicare Limited
- percentToNAV: 0.7%
-
33:
- srNo: 34
- nameOfSecurity: Rubicon Research Limited
- percentToNAV: 0.66%
-
34:
- srNo: 35
- nameOfSecurity: GlaxoSmithKline Pharmaceuticals Limited
- percentToNAV: 0.63%
-
35:
- srNo: 36
- nameOfSecurity: Anthem Biosciences Limited
- percentToNAV: 0.55%
-
36:
- srNo: 37
- nameOfSecurity: Emcure Pharmaceuticals Ltd
- percentToNAV: 0.49%
-
37:
- srNo: 38
- nameOfSecurity: Natco Pharma Limited
- percentToNAV: 0.48%
-
38:
- srNo: 39
- nameOfSecurity: Syngene International Limited
- percentToNAV: 0.48%
-
39:
- srNo: 40
- nameOfSecurity: Jubilant Pharmova Limited
- percentToNAV: 0.46%
-
40:
- srNo: 41
- nameOfSecurity: Vijaya Diagnostic Centre Limited
- percentToNAV: 0.45%
-
41:
- srNo: 42
- nameOfSecurity: Cohance Lifesciences Limited
- percentToNAV: 0.45%
-
42:
- srNo: 43
- nameOfSecurity: Strides Pharma Science Limited
- percentToNAV: 0.44%
-
43:
- srNo: 44
- nameOfSecurity: Marksans Pharma Limited
- percentToNAV: 0.41%
-
44:
- srNo: 45
- nameOfSecurity: Rainbow Childrens Medicare Limited
- percentToNAV: 0.39%
-
45:
- srNo: 46
- nameOfSecurity: Indegene Limited
- percentToNAV: 0.38%
-
46:
- srNo: 47
- nameOfSecurity: Eris LifeSciences Limited
- percentToNAV: 0.37%
-
47:
- srNo: 48
- nameOfSecurity: Metropolis Healthcare Limited
- percentToNAV: 0.36%
-
48:
- srNo: 49
- nameOfSecurity: Pfizer Limited
- percentToNAV: 0.35%
-
49:
- srNo: 50
- nameOfSecurity: Poly Medicure Limited
- percentToNAV: 0.34%
-
50:
- srNo: 51
- nameOfSecurity: Manipal Health Enterprises Ltd
- percentToNAV: 0.33%
-
51:
- srNo: 52
- nameOfSecurity: Jupiter Life Line Hospitals Limited
- percentToNAV: 0.3%
-
52:
- srNo: 53
- nameOfSecurity: Caplin Point Laboratories Limited
- percentToNAV: 0.29%
-
53:
- srNo: 54
- nameOfSecurity: Procter & Gamble Health Limited
- percentToNAV: 0.28%
-
54:
- srNo: 55
- nameOfSecurity: Aarti Pharmalabs Limited
- percentToNAV: 0.28%
-
55:
- srNo: 56
- nameOfSecurity: Alembic Pharmaceuticals Limited
- percentToNAV: 0.27%
-
56:
- srNo: 57
- nameOfSecurity: Alivus Life Sciences Limited
- percentToNAV: 0.27%
-
57:
- srNo: 58
- nameOfSecurity: Bliss GVS Pharma Limited
- percentToNAV: 0.27%
-
58:
- srNo: 59
- nameOfSecurity: Concord Biotech Limited
- percentToNAV: 0.26%
-
59:
- srNo: 60
- nameOfSecurity: Corona Remedies Limited
- percentToNAV: 0.25%
-
60:
- srNo: 61
- nameOfSecurity: AstraZeneca Pharma India Limited
- percentToNAV: 0.25%
-
61:
- srNo: 62
- nameOfSecurity: Yatharth Hospital And Trauma Care Services Limited
- percentToNAV: 0.25%
-
62:
- srNo: 63
- nameOfSecurity: Morepen Laboratories Limited
- percentToNAV: 0.24%
-
63:
- srNo: 64
- nameOfSecurity: Dr Agarwals Health Care Limited
- percentToNAV: 0.24%
-
64:
- srNo: 65
- nameOfSecurity: Viyash Scientific Limited
- percentToNAV: 0.21%
-
65:
- srNo: 66
- nameOfSecurity: Healthcare Global Enterprises Limited
- percentToNAV: 0.19%
-
66:
- srNo: 67
- nameOfSecurity: Sanofi India Limited
- percentToNAV: 0.18%
-
67:
- srNo: 68
- nameOfSecurity: Thyrocare Technologies Limited
- percentToNAV: 0.18%
-
68:
- srNo: 69
- nameOfSecurity: Senores Pharmaceuticals Limited
- percentToNAV: 0.18%
-
69:
- srNo: 70
- nameOfSecurity: Kovai Medical Center and Hospital Limited
- percentToNAV: 0.17%
-
70:
- srNo: 71
- nameOfSecurity: Akums Drugs and Pharmaceuticals Limited
- percentToNAV: 0.16%
-
71:
- srNo: 72
- nameOfSecurity: Sanofi Consumer Healthcare India Limited
- percentToNAV: 0.14%
-
72:
- srNo: 73
- nameOfSecurity: Nephrocare Health Services Ltd
- percentToNAV: 0.14%
-
73:
- srNo: 74
- nameOfSecurity: Supriya Lifescience Limited
- percentToNAV: 0.14%
-
74:
- srNo: 75
- nameOfSecurity: IOL Chemicals and Pharmaceuticals Limited
- percentToNAV: 0.12%
-
75:
- srNo: 76
- nameOfSecurity: Blue Jet Healthcare Ltd
- percentToNAV: 0.12%
-
76:
- srNo: 77
- nameOfSecurity: Suven Life Sciences Limited
- percentToNAV: 0.12%
-
77:
- srNo: 78
- nameOfSecurity: FDC Limited
- percentToNAV: 0.11%
-
78:
- srNo: 79
- nameOfSecurity: Ind-Swift Laboratories Limited
- percentToNAV: 0.11%
-
79:
- srNo: 80
- nameOfSecurity: Sun Pharma Advanced Research Company Limited
- percentToNAV: 0.1%
-
80:
- srNo: 81
- nameOfSecurity: Innova Captab Limited
- percentToNAV: 0.1%
-
81:
- srNo: 82
- nameOfSecurity: Park Medi World Limited
- percentToNAV: 0.1%
-
82:
- srNo: 83
- nameOfSecurity: Shukra Pharmaceuticals Limited
- percentToNAV: 0.1%
-
83:
- srNo: 84
- nameOfSecurity: Kwality Pharmaceuticals Limited
- percentToNAV: 0.1%
-
84:
- srNo: 85
- nameOfSecurity: Aarti Drugs Limited
- percentToNAV: 0.1%
-
85:
- srNo: 86
- nameOfSecurity: Solara Active Pharma Sciences Limited
- percentToNAV: 0.1%
-
86:
- srNo: 87
- nameOfSecurity: SMS Pharmaceuticals Limited
- percentToNAV: 0.09%
-
87:
- srNo: 88
- nameOfSecurity: Artemis Medicare Services Limited
- percentToNAV: 0.09%
-
88:
- srNo: 89
- nameOfSecurity: Indraprastha Medical Corporation Limited
- percentToNAV: 0.08%
-
89:
- srNo: 90
- nameOfSecurity: Orchid Pharma Limited
- percentToNAV: 0.08%
-
90:
- srNo: 91
- nameOfSecurity: Advanced Enzyme Technologies Limited
- percentToNAV: 0.08%
-
91:
- srNo: 92
- nameOfSecurity: Novartis India Limited
- percentToNAV: 0.08%
-
92:
- srNo: 93
- nameOfSecurity: Gujarat Themis Biosyn Ltd
- percentToNAV: 0.07%
-
93:
- srNo: 94
- nameOfSecurity: Gufic Biosciences Limited
- percentToNAV: 0.07%
-
94:
- srNo: 95
- nameOfSecurity: RPG Life Sciences Limited
- percentToNAV: 0.07%
-
95:
- srNo: 96
- nameOfSecurity: Unichem Laboratories Limited
- percentToNAV: 0.06%
-
96:
- srNo: 97
- nameOfSecurity: Fredun Pharmaceuticals Ltd
- percentToNAV: 0.06%
-
97:
- srNo: 98
- nameOfSecurity: Venus Remedies Limited
- percentToNAV: 0.06%
-
98:
- srNo: 99
- nameOfSecurity: Dishman Carbogen Amcis Limited
- percentToNAV: 0.06%
-
99:
- srNo: 100
- nameOfSecurity: Krsnaa Diagnostics Limited
- percentToNAV: 0.06%
-
100:
- srNo: 101
- nameOfSecurity: Syncom Formulations India Limited
- percentToNAV: 0.06%
-
101:
- srNo: 102
- nameOfSecurity: Hester Biosciences Limited
- percentToNAV: 0.05%
-
102:
- srNo: 103
- nameOfSecurity: Hikal Limited
- percentToNAV: 0.05%
-
103:
- srNo: 104
- nameOfSecurity: Indoco Remedies Limited
- percentToNAV: 0.05%
-
104:
- srNo: 105
- nameOfSecurity: Amrutanjan Health Care Limited
- percentToNAV: 0.05%
-
105:
- srNo: 106
- nameOfSecurity: Vimta Labs Limited
- percentToNAV: 0.05%
-
106:
- srNo: 107
- nameOfSecurity: Windlas Biotech Limited
- percentToNAV: 0.04%
-
107:
- srNo: 108
- nameOfSecurity: Anlon Healthcare Limited
- percentToNAV: 0.04%
-
108:
- srNo: 109
- nameOfSecurity: Dr.Agarwals Eye Hospital Limited
- percentToNAV: 0.04%
-
109:
- srNo: 110
- nameOfSecurity: Kopran Limited
- percentToNAV: 0.04%
-
110:
- srNo: 111
- nameOfSecurity: 3B BlackBio Dx Limited
- percentToNAV: 0.04%
-
111:
- srNo: 112
- nameOfSecurity: Sigachi Industries Limited
- percentToNAV: 0.04%
-
112:
- srNo: 113
- nameOfSecurity: Suraksha Diagnostic Limited
- percentToNAV: 0.04%
-
113:
- srNo: 114
- nameOfSecurity: Sai Parenterals Limited
- percentToNAV: 0.04%
-
114:
- srNo: 115
- nameOfSecurity: Fischer Medical Ventures Limited
- percentToNAV: 0.04%
-
115:
- srNo: 116
- nameOfSecurity: KMC Speciality Hospitals (India) Limited
- percentToNAV: 0.04%
-
116:
- srNo: 117
- nameOfSecurity: Panacea Biotec Limited
- percentToNAV: 0.03%
-
117:
- srNo: 118
- nameOfSecurity: Lincoln Pharmaceuticals Limited
- percentToNAV: 0.03%
-
118:
- srNo: 119
- nameOfSecurity: Tarsons Products Limited
- percentToNAV: 0.03%
-
119:
- srNo: 120
- nameOfSecurity: NGL Fine Chem Limited
- percentToNAV: 0.03%
-
120:
- srNo: 121
- nameOfSecurity: Fermenta Biotech Limited
- percentToNAV: 0.02%
-
121:
- srNo: 122
- nameOfSecurity: Bajaj Healthcare Limited
- percentToNAV: 0.02%
-
122:
- srNo: 123
- nameOfSecurity: Jagsonpal Pharmaceuticals Limited
- percentToNAV: 0.02%
-
123:
- srNo: 124
- nameOfSecurity: GPT Healthcare Limited
- percentToNAV: 0.02%
-
124:
- srNo: 125
- nameOfSecurity: Wanbury Limited
- percentToNAV: 0.02%
-
125:
- srNo: 126
- nameOfSecurity: Gujarat Kidney And Super Speciality Limited
- percentToNAV: 0.02%
-
126:
- srNo: 127
- nameOfSecurity: Laxmi Dental Limited
- percentToNAV: 0.02%
-
127:
- srNo: 128
- nameOfSecurity: Shalby Limited
- percentToNAV: 0.02%
-
128:
- srNo: 129
- nameOfSecurity: Themis Medicare Ltd
- percentToNAV: 0.02%
-
129:
- srNo: 130
- nameOfSecurity: Anuh Pharma Ltd
- percentToNAV: 0.02%
-
130:
- srNo: 131
- nameOfSecurity: Kilitch Drugs (India) Limited
- percentToNAV: 0.01%
-
131:
- srNo: 132
- nameOfSecurity: Gaudium IVF and Women Health Limited
- percentToNAV: 0.01%
-
132:
- srNo: 133
- nameOfSecurity: One Global Service Provider Limited
- percentToNAV: 0.01%
-
133:
- srNo: 134
- nameOfSecurity: MEDICAMEN BIOTECH LIMITED
- percentToNAV: 0.01%
-
134:
- srNo: 135
- nameOfSecurity: Ambalal Sarabhai Enterprises Limited
- percentToNAV: 0.01%
-
135:
- srNo: 136
- nameOfSecurity: Fabtech Technologies Limited
- percentToNAV: 0.01%
-
136:
- srNo: 137
- nameOfSecurity: Take Limited
- percentToNAV: 0.01%
-
137:
- srNo: 138
- nameOfSecurity: Gennex Laboratories Ltd
- percentToNAV: 0.01%
-
138:
- srNo: 139
- nameOfSecurity: Medico Remedies Limited
- percentToNAV: $0.00%
-
-
sector:
-
0:
- sector: Pharmaceuticals & Biotechnology
- percentage: 78.39%
-
1:
- sector: Healthcare Services
- percentage: 21.09%
-
2:
- sector: Healthcare Equipment & Supplies
- percentage: 0.44%
-
3:
- sector: Cash & Equivalent
- percentage: 0.09%
-
Industry Classification as recommended by AMFI
-
-
Key Facts
- Launched on 06 Feb 2024
-
Investment Objective
-
trackingerror:0.03 % (From 11 Mar 2025 to 10 Mar 2026)
-
methodology:
a) Methodology of calculating sale price: The price or NAV, an investor is charged while investing in anopen-ended scheme is called sale or subscription price. Pursuant toSEBI Circular dated June 30, 2009, no entry load will be chargedby the scheme to the investors. Therefore, Sale or Subscriptionprice = Applicable NAV (for respective plan and option of thescheme)
Example: An investor invests Rs.10,000/- and the current NAV isRs. 10/- then the purchase price will be Rs.10/- and the investorreceives 10,000/10 = 1000 units.
b) Methodology of calculating repurchase price of Units: Repurchase or redemption price is the price or NAV at which anopen-ended scheme purchases or redeems its units from theinvestors. It may include exit load, if applicable. The exit load, ifany, shall be charged as a percentage of Net Assets Value (NAV)i.e. applicable load as a percentage of NAV will be deducted fromthe ÒApplicable NAVÓ to calculate the repurchase price.Therefore, Repurchase or Redemption Price = Applicable NAV*(1- Exit Load, if any)
Example: If the Applicable NAV is Rs. 10 and a 2% Exit Load ischarged, the Redemption Price per Unit will be calculated asfollows: = Rs. 10 * (1-0.02) = Rs. 10 * (0.98) = Rs. 9.80
-
indexMethodology:
Index Methodology: Click here
Historic Changes in Index Constituents: Click here
-
investmentObjective:
The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by BSE Healthcare TRI, subject to tracking error. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved
-
applicationAmount:
Through Stock Exchange - 1 Unit & in multiples thereof.
-
redemptionAmont: Through Stock Exchange - 1 Unit & in multiples thereof.
-
exitLoad:
NIL
-
aum:
-
0:
- latestAum: 44.4991
- latestAumAsOnDt: 2026-10-31T00:00:00
- optioncode: G
- plancode: GR
- prodcode: SHGR
-
-
portfolioTurnoverRatio: 0.16
-
planList:
-
0:
- sixth_char_name: R
- planNameOriginal: Regular Growth
- groupedCode: GRG
- groupedName: Regular-Growth
- optionCode: G
- optionName: Growth
- planCode: GR
- planName: Regular
- schDetail:
- fundCategoryCode:
- cfReferencePath: /content/dam/motilal-mf/content-fragment/plan-code-model-fragment/regular-growth-etf
- dlPKey: DL_MF_SH_GR_GR
- isin: INF247L01BB1
- amfi_schcode: 150445
- cmt_schcode: 42978
-
-
benchmark: BSE Healthcare TRI
-
expenseRatioDirect: NIL
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-10-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 8.637157535347729
- inception_Ret: 10.705736641984554
- bmcode: 2046.0
- oneYear_marketValue: 10000.0
- threeYear_marketValue: 12821.395279847478
- inception_marketValue: 15423.283393834985
-
-
entryLoad:
NIL
Minimum Application Amount
₹500/- and in multiples of ₹1/- thereafter
Minimum Redemption Amount
₹500/- then ₹1/- increments, up to account balance
Latest AUM
44.4991
2026-10-31T00:00:00
Portfolio Turnover Ratio
0.16
Plans
Regular
Options (Under each plan)
Growth
Benchmark
BSE Healthcare TRI
Total Expense Ratio
NIL
Inception date
2026-10-31
Entry Load
NIL
Exit Load Policy
Our Fund Managers
Managing this fund since
Total AUM
-
-
schDetail
-
exitLoad:
NIL
-
nfoStartDate: 13-Jul-2022
-
sebiCategory: ETF Fund
-
cmotsGroupCode: MO42978
-
dateOfAllotment: 2022-07-29
-
schemeName: Motilal Oswal BSE Healthcare ETF
-
nfoEndDate: 21-Jul-2022
-
fundCategoryCode: ETF
-
schcode: SH
-
-
fundManager:
-
0:
-
description:
Swapnil has over 12 years of experience in the fund management and product development.
Motilal Oswal Asset Management Company Ltd. from March 2010 onwards.
Business Standard, Research Associate from August 2005 to February 2010.
-
designation: Fund Manager
-
picture: /content/dam/motilal-mf/fund-manager/mr-swapnil-mayekar.png
-
fundManagerName: Swapnil Mayekar
-
type: MF
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/swapnil-mayekar
-
-
1:
-
description:
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
-
designation: Head Debt
-
picture: /content/dam/motilal-mf/fund-manager/mr-rakesh-shetty.png
-
fundManagerName: Rakesh Shetty
-
type: MF
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/rakesh-shetty
-
-
2:
-
description:
Mr. Dishant Mehta has more than 11 years of experience and expertise in Financial markets across different segment -Equities, Derivatives, Commodities and Currencies. Managed Institutional and Foreign Portfolio Investment clients. Prior to joining Motilal Oswal Asset Management Company, Mr. Mehta has worked with Emkay Global Financial Services Limited, Anand Rathi Shares & Stock Brokers Limited, Kotak Securities Limited and Angel Broking Limited.
-
designation: Associate Fund Manager and Passive Dealer
-
picture: /content/dam/motilal-mf/fund-manager/mr-dishant-mehta.png
-
fundManagerName: Dishant Mehta
-
type: MF
-
dropdownField: MF
-
cfReferencePath: /content/dam/motilal-mf/content-fragment/fund-manager/dishant-mehta
-
-
Downloads
-
- Factsheet
-
- Presentation
-
- Brochures
-
- Scheme information document
-
- Forms
-
- Index Component
- portfolioUrl/content/dam/motilal-mf/sheets/fund-csvs/Month_End_Portfolio_October_2026/YO36.xlsx
- brochurepdf
- latestFactsheetPdf/content/dam/motilal-mf/downloads/mf/factsheet/2026/oct/Factsheet September 2026 Passive.pdf
- presentationPdf/content/dam/motilal-mf/downloads/mf/presentations/2026/oct/Presentation - Motilal Oswal BSE Healthcare ETF - Sep 2026.pdf
- sidDocumentPdf/content/dam/motilal-mf/downloads/mf/sid/2026/may/SID_Motilal Oswal BSE Healthcare ETF.pdf
- formPdf
- indexComponent/content/dam/motilal-mf/sheets/index-component/SH.xlsx
Product Label
This product is suitable for investors who are seeking*
- Long term capital growth
- Investments in equity and equity related instruments of large cap stocks.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
-
productLabellingDescription:
This product is suitable for investors who are seeking*
- Return that corresponds to the performance of BSE Healthcare Total Return Index subject to tracking error.
- Long term capital growth.
-
benchmarkreturns:
-
0:
- type: BM
- groupName: BSE Healthcare TRI (PRIMARY)
- latNavDate: 2026-10-31
- latnav: 40107.94
- oneYear_Ret: 0.0
- threeYear_Ret: 8.637157535347729
- inception_Ret: 10.705736641984554
- bmcode: 2046.0
- oneYear_marketValue: 10000.0
- threeYear_marketValue: 12821.395279847478
- inception_marketValue: 15423.283393834985
-
-
schDetail
-
exitLoad:
NIL
-
nfoStartDate: 13-Jul-2022
-
sebiCategory: ETF Fund
-
cmotsGroupCode: MO42978
-
dateOfAllotment: 2022-07-29
-
schemeName: Motilal Oswal BSE Healthcare ETF
-
nfoEndDate: 21-Jul-2022
-
fundCategoryCode: ETF
-
schcode: SH
-
-
risk
- riskType: Very High
- riskImageURL: https://www.motilaloswalmf.com/content/dam/motilal-mf/risk-meter-images/risk-meter/very-high-risk.png
- benchmarkRisk: Very High
- benchmarkRiskImageURL: https://www.motilaloswalmf.com/content/dam/motilal-mf/risk-meter-images/benchmark/very-high-risk.png
Frequently Asked Questions
Are ETFs a good investment?
How can beginners invest in ETFs?
Can I buy and sell ETFs anytime?
How much money do I need to start investing in ETFs?
Is it better to invest in ETFs for the short-term or long-term?
Can I start a SIP in an ETF?
What is the average return on ETFs in India?
Is ETF taxable in India?
What is better, ETF or mutual funds?
What is the entry/exit load for ETFs?
How to buy ETF?
Do ETFs pay dividends?
Is ETF an active or a passive fund?
- Motilal Oswal Asset Allocation Passive Fund Conservative
Invest Now